Pulmonary Embolism and Chronic Obstructive Pulmonary Disease

Area of Science:

• Pulmonary Medicine
• Cardiology
• Critical Care

Background:

• Chronic obstructive pulmonary disease (COPD) is a leading cause of death globally, characterized by persistent dyspnea and exacerbations.
• Hospitalization for respiratory failure in COPD patients is a significant risk factor for venous thromboembolism (VTE).
• COPD is a moderate risk factor for VTE, with an odds ratio of 2-9, comparable to cancer or oral contraceptives.

Purpose of the Study:

• To review the epidemiology, clinical presentation, and prognosis of pulmonary embolism (PE) in COPD patients.
• To present findings from the Prevalence de l'Embolie Pulmonaire chez les patients admis pour exacerbation de BPCO study on PE frequency in hospitalized COPD exacerbations.
• To discuss the Significance of Pulmonary Embolism in COPD Exacerbations (SPICE) trial comparing systematic PE search versus routine care.

Main Methods:

• Literature review of epidemiological data and clinical presentations of PE in COPD.
• Analysis of the Prevalence de l'Embolie Pulmonaire chez les patients admis pour exacerbation de BPCO study data.
• Review of the SPICE randomized trial comparing diagnostic strategies for PE in COPD exacerbations.

Main Results:

• COPD exacerbations can mimic PE symptoms, and PE can worsen COPD prognosis.
• The Prevalence de l'Embolie Pulmonaire study aimed to quantify PE frequency in hospitalized COPD exacerbations.
• The SPICE trial evaluated the impact of systematic PE investigation on patient outcomes during COPD exacerbations.

Conclusions:

• The association between COPD and VTE, particularly PE, requires careful consideration due to overlapping symptoms and prognostic implications.
• Further research is needed to address unmet needs in managing PE in COPD patients.
• Systematic evaluation for PE may be warranted in COPD exacerbations, especially in high-risk individuals.